268 related articles for article (PubMed ID: 33839680)
1. Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting β-III-spectrin.
Rebbeck RT; Andrick AK; Denha SA; Svensson B; Guhathakurta P; Thomas DD; Hays TS; Avery AW
J Biol Chem; 2021; 296():100215. PubMed ID: 33839680
[TBL] [Abstract][Full Text] [Related]
2. Early-phase drug discovery of β-III-spectrin actin-binding modulators for treatment of spinocerebellar ataxia type 5.
Guhathakurta P; Rebbeck RT; Denha SA; Keller AR; Carter AL; Atang AE; Svensson B; Thomas DD; Hays TS; Avery AW
J Biol Chem; 2023 Mar; 299(3):102956. PubMed ID: 36731793
[TBL] [Abstract][Full Text] [Related]
3. A human β-III-spectrin spinocerebellar ataxia type 5 mutation causes high-affinity F-actin binding.
Avery AW; Crain J; Thomas DD; Hays TS
Sci Rep; 2016 Feb; 6():21375. PubMed ID: 26883385
[TBL] [Abstract][Full Text] [Related]
4. Increased Actin Binding Is a Shared Molecular Consequence of Numerous SCA5 Mutations in β-III-Spectrin.
Atang AE; Keller AR; Denha SA; Avery AW
Cells; 2023 Aug; 12(16):. PubMed ID: 37626910
[TBL] [Abstract][Full Text] [Related]
5. β-III-spectrin N-terminus is required for high-affinity actin binding and SCA5 neurotoxicity.
Denha SA; Atang AE; Hays TS; Avery AW
Sci Rep; 2022 Feb; 12(1):1726. PubMed ID: 35110634
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for high-affinity actin binding revealed by a β-III-spectrin SCA5 missense mutation.
Avery AW; Fealey ME; Wang F; Orlova A; Thompson AR; Thomas DD; Hays TS; Egelman EH
Nat Commun; 2017 Nov; 8(1):1350. PubMed ID: 29116080
[TBL] [Abstract][Full Text] [Related]
7. β-III-spectrin spinocerebellar ataxia type 5 mutation reveals a dominant cytoskeletal mechanism that underlies dendritic arborization.
Avery AW; Thomas DD; Hays TS
Proc Natl Acad Sci U S A; 2017 Oct; 114(44):E9376-E9385. PubMed ID: 29078305
[TBL] [Abstract][Full Text] [Related]
8. Beta-III spectrin mutation L253P associated with spinocerebellar ataxia type 5 interferes with binding to Arp1 and protein trafficking from the Golgi.
Clarkson YL; Gillespie T; Perkins EM; Lyndon AR; Jackson M
Hum Mol Genet; 2010 Sep; 19(18):3634-41. PubMed ID: 20603325
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput Spectral and Lifetime-Based FRET Screening in Living Cells to Identify Small-Molecule Effectors of SERCA.
Schaaf TM; Peterson KC; Grant BD; Bawaskar P; Yuen S; Li J; Muretta JM; Gillispie GD; Thomas DD
SLAS Discov; 2017 Mar; 22(3):262-273. PubMed ID: 27899691
[TBL] [Abstract][Full Text] [Related]
10. Increased actin binding is a shared molecular consequence of numerous spinocerebellar ataxia mutations in β-III-spectrin.
Atang AE; Keller AR; Denha SA; Avery AW
bioRxiv; 2023 Apr; ():. PubMed ID: 36865188
[TBL] [Abstract][Full Text] [Related]
11. High-throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin-myosin structure and function.
Guhathakurta P; Prochniewicz E; Grant BD; Peterson KC; Thomas DD
J Biol Chem; 2018 Aug; 293(31):12288-12298. PubMed ID: 29866882
[TBL] [Abstract][Full Text] [Related]
12. Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen.
Bunch TA; Guhathakurta P; Lepak VC; Thompson AR; Kanassatega RS; Wilson A; Thomas DD; Colson BA
J Biol Chem; 2021 Jul; 297(1):100840. PubMed ID: 34052227
[TBL] [Abstract][Full Text] [Related]
13. Probing Interdomain Linkers and Protein Supertertiary Structure In Vitro and in Live Cells with Fluorescent Protein Resonance Energy Transfer.
Basak S; Sakia N; Dougherty L; Guo Z; Wu F; Mindlin F; Lary JW; Cole JL; Ding F; Bowen ME
J Mol Biol; 2021 Mar; 433(5):166793. PubMed ID: 33388290
[TBL] [Abstract][Full Text] [Related]
14. Spectrin mutations that cause spinocerebellar ataxia type 5 impair axonal transport and induce neurodegeneration in Drosophila.
Lorenzo DN; Li MG; Mische SE; Armbrust KR; Ranum LP; Hays TS
J Cell Biol; 2010 Apr; 189(1):143-58. PubMed ID: 20368622
[TBL] [Abstract][Full Text] [Related]
15. Spinocerebellar ataxia type 5.
Dick KA; Ikeda Y; Day JW; Ranum LP
Handb Clin Neurol; 2012; 103():451-9. PubMed ID: 21827906
[TBL] [Abstract][Full Text] [Related]
16. β-III spectrin underpins ankyrin R function in Purkinje cell dendritic trees: protein complex critical for sodium channel activity is impaired by SCA5-associated mutations.
Clarkson YL; Perkins EM; Cairncross CJ; Lyndon AR; Skehel PA; Jackson M
Hum Mol Genet; 2014 Jul; 23(14):3875-82. PubMed ID: 24603075
[TBL] [Abstract][Full Text] [Related]
17. The actin binding domain of βI-spectrin regulates the morphological and functional dynamics of dendritic spines.
Nestor MW; Cai X; Stone MR; Bloch RJ; Thompson SM
PLoS One; 2011 Jan; 6(1):e16197. PubMed ID: 21297961
[TBL] [Abstract][Full Text] [Related]
18. FRET-based calcium imaging: a tool for high-throughput/content phenotypic drug screening in Alzheimer disease.
Honarnejad K; Kirsch AK; Daschner A; Szybinska A; Kuznicki J; Herms J
J Biomol Screen; 2013 Dec; 18(10):1309-20. PubMed ID: 24221842
[TBL] [Abstract][Full Text] [Related]
19. Spectral Unmixing Plate Reader: High-Throughput, High-Precision FRET Assays in Living Cells.
Schaaf TM; Peterson KC; Grant BD; Thomas DD; Gillispie GD
SLAS Discov; 2017 Mar; 22(3):250-261. PubMed ID: 27879398
[TBL] [Abstract][Full Text] [Related]
20. The carboxyterminal EF domain of erythroid alpha-spectrin is necessary for optimal spectrin-actin binding.
Korsgren C; Lux SE
Blood; 2010 Oct; 116(14):2600-7. PubMed ID: 20585040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
